Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 8
317
Views
7
CrossRef citations to date
0
Altmetric
Short Communications

An iboga alkaloid chemotaxonomic marker from endemic Tabernaemontana ternifolia with antitubercular activity

, ORCID Icon, , , &
Pages 1175-1179 | Received 21 May 2018, Accepted 17 Nov 2018, Published online: 17 Feb 2019
 

Abstract

Coronaridine (1) was isolated from the CH2Cl2 root extract of Tabernaemontana ternifolia. The structure of 1 was established from 1D- and 2D-NMR and HR-ESIMS experiments, and by comparison with reported spectroscopic data. To date, this is the first report of compound 1 from T. ternifolia, introduced as new Tabernaemontana species from Philippines in 2005 on the basis of morphological characters. Coronaridine, an iboga-type indole alkaloid, has been isolated from over 50 Tabernaemontana species and can thus be inferred as a chemotaxonomic marker of the genus. T. ternifolia has a distinct arrangement of leaves not known in the genus, but is variable in other genera. Its isolation from endemic T. ternifolia establishes its position in the genus and supports the claim that coronaridine is a chemical marker of the genus Tabernaemontana. Interestingly, coronaridine exhibited relatively weak activity against Mycobacterium tuberculosis H37Rv (MIC 82.64 μg/mL) (Rifampicin MIC 0.05 μg/mL).

Graphical Abstract

Acknowledgments

RCG acknowledges the DOST-SEI ASTHRDP and the CHED-FDP for the Ph.D. research grants; the Palawan Council for Sustainable Development for permitting plant collection in a protected area; and Prof. Norman G. Lewis for allowing the final stages of compound purification to be conducted at the Institute of Biological Chemistry, Washington State University. It is also acknowledged that a portion of this research was performed using EMSL, a U.S. DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.